References(28)
[1]
Mangin G, Kubis N. Cell therapy for ischemic stroke: How to turn a promising preclinical research into a successful clinical story. Stem Cell Rev. 2019, 15(2): 176-193.
[2]
Baker EW, Kinder HA, West FD. Neural stem cell therapy for stroke: A multimechanistic approach to restoring neurological function. Brain Behav. 2019, 9(3): e01214. .
[3]
Augestad IL, Nyman AKG, Costa AI, et al. Effects of neural stem cell and olfactory ensheathing cell Co-transplants on tissue remodelling after transient focal cerebral ischemia in the adult rat. Neurochem Res. 2017, 42(6): 1599-1609.
[4]
Su ZD, He C. Olfactory ensheathing cells: biology in neural development and regeneration. Prog Neurobiol. 2010, 92(4): 517-532.
[5]
Shukla S, Chaturvedi RK, Seth K, et al. Enhanced survival and function of neural stem cells-derived dopaminergic neurons under influence of olfactory ensheathing cells in parkinsonian rats. J Neurochem. 2009, 109(2): 436-451.
[6]
Ma ZG, Stork T, Bergles DE, et al. Neuromodulators signal through astrocytes to alter neural circuit activity and behaviour. Nature. 2016, 539(7629): 428-432.
[7]
Dairaghi L, Flannery E, Giacobini P, et al. Reelin can modulate migration of olfactory ensheathing cells and gonadotropin releasing hormone neurons via the canonical pathway. Front Cell Neurosci. 2018, 12: 228.
[8]
Zhang JY, Chen HJ, Duan ZX, et al. The effects of Co- transplantation of olfactory ensheathing cells and schwann cells on local inflammation environment in the contused spinal cord of rats. Mol Neurobiol. 2017, 54(2): 943-953.
[9]
Khankan RR, Griffis KG, Haggerty-Skeans JR, et al. Olfactory ensheathing cell transplantation after a complete spinal cord transection mediates neuroprotective and immunomodulatory mechanisms to facilitate regeneration. J Neurosci. 2016, 36(23): 6269-6286.
[10]
Gómez RM, Sánchez MY, Portela-Lomba M, et al. Cell therapy for spinal cord injury with olfactory ensheathing glia cells (OECs). Glia. 2018, 66(7): 1267-1301.
[11]
Yang H, He BR, Hao DJ. Biological roles of olfactory ensheathing cells in facilitating neural regeneration: a systematic review. Mol Neurobiol. 2015, 51(1): 168-179.
[12]
Xiao J, Chen L, Mao GS, et al. Neurorestorative clinical application standards for the culture and quality control of olfactory ensheathing cells. J Neurorestoratology. 2017, 5: 175-179.
[13]
Caprio FZ, Sorond FA. Cerebrovascular disease. Med Clin N Am. 2019, 103(2): 295-308.
[14]
Zhong CK, Zhu ZB, Wang AL, et al. Multiple biomarkers covering distinct pathways for predicting outcomes after ischemic stroke. Neurology. 2019, 92(4): e295-e304.
[15]
Donkor ES. Stroke in the 21st century: A snapshot of the burden, epidemiology, and quality of life. Stroke Res Treat. 2018, 2018: 3238165.
[16]
Jendelová P, Kubinová Š, Sandvig I, et al. Current developments in cell- and biomaterial-based approaches for stroke repair. Expert Opin Biol Ther. 2016, 16(1): 43-56.
[17]
Chen L, Xi HT, Huang HY, et al. Multiple cell transplantation based on an intraparenchymal approach for patients with chronic phase stroke. Cell Transplant. 2013, 22(Suppl 1): S83-S91.
[18]
Guzman R, Choi R, Gera A, et al. Intravascular cell replacement therapy for stroke. Neurosurg Focus. 2008, 24(3/4): E15. .
[19]
Gopurappilly R, Pal R, Mamidi MK, et al. Stem cells in stroke repair: current success and future prospects. CNS Neurol Disord Drug Targets. 2011, 10(6): 741-756.
[20]
Roet KC, Franssen EH, de Bree FM, et al. A multilevel screening strategy defines a molecular fingerprint of proregenerative olfactory ensheathing cells and identifies SCARB2, a protein that improves regenerative sprouting of injured sensory spinal axons. J Neurosci. 2013, 33(27): 11116-11135.
[21]
Shapiro LA, Ng KL, Zhou QY, et al. Olfactory enrichment enhances the survival of newly Born cortical neurons in adult mice. Neuroreport. 2007, 18(10): 981-985.
[22]
Li C, Zhang B, Tian S, et al. Early wheel-running promotes functional recovery by improving mitochondria metabolism in olfactory ensheathing cells after ischemic stroke in rats. Behav Brain Res. 2019, 361: 32-38.
[23]
Chou RH, Lu CY, Lee W, et al. The potential therapeutic applications of olfactory ensheathing cells in regenerative medicine. Cell Transplant. 2014, 23(4/5): 567-571.
[24]
Huang HY, Young W, Chen L, et al. Clinical cell therapy guidelines for neurorestoration (IANR/CANR 2017). Cell Transplant. 2018, 27(2): 310-324.
[25]
Huang HY, Chen L, Xi HT, et al. Olfactory ensheathing cells transplantation for central nervous system diseases in 1,255 patients (in Chinese). Chin J Repar Reconstruc Surg. 2009, 23(1): 14-20.
[26]
Giordana MT, Grifoni S, Votta B, et al. Neuropathology of olfactory ensheathing cell transplantation into the brain of two amyotrophic lateral sclerosis (ALS) patients. Brain Pathol. 2010, 20(4): 730-737.
[27]
Chen L, Huang HY, Xi HT, et al. Intracranial transplant of olfactory ensheathing cells in children and adolescents with cerebral palsy: a randomized controlled clinical trial. Cell Transplant. 2010, 19(2): 185-191.
[28]
Chen L, Huang HY, Xi HT, et al. A prospective randomized double-blind clinical trial using a combination of olfactory ensheathing cells and Schwann cells for the treatment of chronic complete spinal cord injuries. Cell Transplant. 2014, 23(Suppl 1): S35-S44.